Xenobiotica · 1983 · 19 citations · 16 references
PharmacotherapyOrganic SolventsRadiopharmaceutical TherapyToxicologyMetabolismSerum Half-livesHuman MetabolismSteroid MetabolismHealth SciencesBiochemistryMetabolomicsPharmacologyEndocrine DisruptorsEnergy MetabolismUrologyPhysiologyPyrazolone RingSerum Half-lifeMedicinePharmacokineticsN-methyl GroupCarbonyl MetabolismDrug Analysis
1. After ingestion of [N-14CH3]antipyrine by two healthy male subjects, the urinary recoveries of radioactivity plus norantipyrine (non-radioactive) were 63 and 73%. After ingestion of [3-14C]antipyrine in the same two subjects, the urinary recoveries of radioactivity were 84 and 99%. Therefore, N-demethylated metabolites which have not been identified before, besides norantipyrine, must account for 21-26% of the dose.2. Serum half-lives of total 14C were about 50% greater than those of unchanged antipyrine. The difference was less in the saliva.3. Three major metabolites of antipyrine, norantipyrine, 4-hydroxyantipyrine and 3-hydroxymethylantipyrine, in urine were determined by radio-t.l.c. and g.l.c. These three metabolites and antipyrine accounted for 50-69% of the administered dose. The urinary excretion half-lives of these three metabolites were similar to each other and to the serum half-life of antipyrine. 3-Hydroxymethylantipyrine in one subject was excreted more slowly than the other metabolites. The radioactive metabolite not extracted from urine by organic solvents was very polar, as judged by t.l.c.
16
The fate of antipyrine in man.
Bernard B. Brodie, Julius Axelrod · PubMed · 1950 · 216 citations
Body Water, Molecular Pharmacology, Endocrine Disruptors +14
Meindert Danhof, de Groot van derVis, DD Breimer · Pharmacology · 1979 · 167 citations
Primary Metabolites, Pharmacotherapy, Reversed Phase System +19